Drug Type Small molecule drug |
Synonyms 17-Acetoxy-6-methylpregna-4,6-diene-3,20-dione, 17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione 17-acetate, 17alpha-Acetoxy-6-dehydro-6-methylprogesterone + [36] |
Target |
Mechanism PR agonists(Progesterone receptor agonists) |
Therapeutic Areas |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (18 Aug 1971), |
RegulationOrphan Drug (US) |
Molecular FormulaC24H32O4 |
InChIKeyRQZAXGRLVPAYTJ-GQFGMJRRSA-N |
CAS Registry595-33-5 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acquired Immunodeficiency Syndrome | US | 18 Aug 1971 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Squamous Cell Carcinoma of Head and Neck | Phase 3 | CN | 01 Jan 2025 | |
Dementia | Phase 3 | ES | 01 Jun 2007 | |
Neoplasms | Phase 3 | US | 01 Jun 2006 | |
Anorexia | Phase 3 | US | 31 Aug 2001 | |
Cachexia | Phase 3 | US | 31 Aug 2001 | |
Pulmonary Disease, Chronic Obstructive | Phase 2 | ES | 01 Oct 2006 | |
HIV Wasting Syndrome | Phase 2 | US | 01 Dec 2004 | |
HIV Wasting Syndrome | Phase 2 | IN | 01 Dec 2004 | |
HIV Wasting Syndrome | Phase 2 | ZA | 01 Dec 2004 | |
Malnutrition | Phase 2 | US | 31 Aug 2001 |
Not Applicable | - | oliejipjdw(fikzykkobt) = hipybqpaql ncjbzhwmwd (yqrasxbpyi ) View more | - | 01 Jun 2024 | |||
Not Applicable | - | cdkxdxpawo(ukkfbvmczb) = ddejktvpvn usckddsdph (bsiilmcrii ) View more | - | 24 May 2024 | |||
Not Applicable | - | nrbfdosedp(oxizrddmjg) = exggpurlha eqkfqdrxoe (bimlbfwnqo ) View more | - | 05 Oct 2023 | |||
iuhdmdeabo(omqwpehnyj) = kgodswjqqv ebzffvcwak (guoghcjwjt ) | |||||||
Phase 2 | Estrogen receptor positive breast cancer ER+ | HER2- | 20 | Megestrol-Acetate (MA) | prltzmysmb(xvwkhjrasn) = fjitfhlxht iavdysakjc (rpzbzkjjbc ) View more | Negative | 12 May 2023 | |
Another Hormone Therapy (AHT) | prltzmysmb(xvwkhjrasn) = ajfaibqdec iavdysakjc (rpzbzkjjbc ) View more | ||||||
Not Applicable | Endometrial Carcinoma estrogen receptor | progesterone receptors | 83 | Tamoxifen-progestin combination therapy | mhrenbjasx(beeiiwpwin) = vvzptrecow nrafpsdspk (zikuedvcrp ) | Positive | 20 Oct 2022 | |
Progestin-only therapy | mhrenbjasx(beeiiwpwin) = lwhtzkawln nrafpsdspk (zikuedvcrp ) | ||||||
Phase 2/3 | 180 | MA+LNG-IUS | gfrlodayyc(rqnggmlubz) = LNG-IUS group had lower incidence of abdominal pain iwoiruuhae (mwyoseugwh ) View more | Positive | 01 Nov 2021 | ||
MA | |||||||
Phase 2 | 150 | (Megestrol Acetate and Metformin) | uufdxrifxw(rkmhxgnyzg) = rsdhljtgkh zqbqvbcagt (qhstiiplqh, vyjasfzdek - ybluzsahxb) View more | - | 13 Sep 2021 | ||
(Megestrol Acetate) | uufdxrifxw(rkmhxgnyzg) = tnugsmlsxp zqbqvbcagt (qhstiiplqh, rmkbbdadup - yhgvdnmdyo) View more | ||||||
Not Applicable | - | Megestrol Acetate (MA) | efynqzdpag(aromdlxelw) = qydndznpgd hsevkndxzj (imftevegai ) View more | Positive | 03 May 2021 | ||
Phase 2 | 9 | Quality-of-Life Assessment+megestrol acetate (Regimen 1 (Megestrol Acetate, Surgery)) | bhqqlbscqr(gamnykktmk) = deetlkwkor crqlnmawbn (llshezecui, ahhchlmfuj - dwmxyuhbmr) View more | - | 14 Oct 2020 | ||
Quality-of-Life Assessment+megestrol acetate (Regimen 2 (Megestrol Acetate, Surgery)) | bhqqlbscqr(gamnykktmk) = sawswntbfr crqlnmawbn (llshezecui, zqjgesjqem - nfmxtnctjf) View more | ||||||
Not Applicable | - | 1 | gxwlgprrda(lqlxqyoujp) = nuohpbknzw cxzoiayuju (eneqsmzjca ) View more | - | 08 May 2020 |